# Laxmi Dental (NSE: LAXMIDENTL) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/LAXMIDENTL · Pivot · prices to 21 Oct 2026

Laxmi Dental (NSE: LAXMIDENTL) closed at ₹177.92 on 21 Oct 2026. With a market capitalisation of ₹1,001 Cr, it ranks 1467th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Instruments & Supplies.

At its last close the stock traded at 34.6× trailing earnings, against a return on equity of 11.9% in FY26. Over the past year the share price has fallen 42.7%. Its 52-week range is ₹155.88 (30 Mar 2026) to ₹344.80 (11 Nov 2025); the last close is 48.4% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹72 Cr (+19.5% year on year) and net profit ₹11 Cr (+201.4%), on a consolidated basis. Promoters held 41.80% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹177.92 |
| Market cap | ₹1,001 Cr |
| P/E (trailing) | 34.6 |
| ROE | 11.9% (FY26) |
| ROCE | 13.7% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹344.80 (11 Nov 2025) |
| 52-week low | ₹155.88 (30 Mar 2026) |
| 1-year return | −42.7% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹72 Cr | +19.5% | ₹11 Cr | +201.4% | ₹1.83 |
| Q3 FY26 | ₹64 Cr | +5.9% | ₹1 Cr | −74.5% | ₹0.37 |
| Q2 FY26 | ₹71 Cr | +25.5% | ₹8 Cr | +102.1% | ₹1.59 |
| Q1 FY26 | ₹64 Cr | +6.8% | ₹7 Cr | −46.8% | ₹1.53 |
| Q4 FY25 | ₹60 Cr | +10.7% | ₹4 Cr | −36.1% | ₹0.79 |
| Q3 FY25 | ₹60 Cr | +27.9% | ₹4 Cr | +810.0% | ₹0.88 |
| Q2 FY25 | ₹57 Cr | — | ₹4 Cr | — | ₹1.14 |
| Q1 FY25 | ₹60 Cr | — | ₹14 Cr | — | ₹4.94 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹239 Cr | ₹25 Cr |
| FY24 | ₹194 Cr | ₹16 Cr |
| FY23 | ₹162 Cr | −₹5 Cr |
| FY22 | ₹137 Cr | −₹19 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 41.80%
- Foreign institutions: 30.10%
- Domestic institutions: 10.89%
- Non-institutions: 17.21%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Bajaj Healthcare](https://app.pivotnow.in/stock/BAJAJHCARE) | ₹339.90 | ₹1,144 Cr | 50.4 | — |
| [Bafna Pharmaceuticals](https://app.pivotnow.in/stock/BAFNAPH) | ₹470.55 | ₹1,113 Cr | 100.3 | — |
| [Lincoln Pharmaceuticals](https://app.pivotnow.in/stock/LINCOLN) | ₹533.40 | ₹1,068 Cr | 12.2 | — |
| [Sigachi Industries](https://app.pivotnow.in/stock/SIGACHI) | ₹26.70 | ₹1,020 Cr | — | — |
| [Themis Medicare](https://app.pivotnow.in/stock/THEMISMED) | ₹100.30 | ₹924 Cr | — | — |
| [Shree Ganesh Re](https://app.pivotnow.in/stock/SGRL) | ₹694.00 | ₹891 Cr | 50.3 | — |

## Questions and answers

### What is the share price of Laxmi Dental today?

Laxmi Dental (NSE: LAXMIDENTL) last closed at ₹177.92 on 21 Oct 2026. Its 52-week high is ₹344.80 and its 52-week low is ₹155.88.

### What is the market cap of Laxmi Dental?

Laxmi Dental's market capitalisation is ₹1,001 Cr (₹1,001 Cr) at the 19 Oct 2026 close, ranking 1467th among the NSE companies Pivot tracks.

### What is the P/E ratio of Laxmi Dental?

Laxmi Dental trades at a trailing P/E of 34.6. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 50.4.

### What is the ROE and ROCE of Laxmi Dental?

Return on equity was 11.9% in FY26 and return on capital employed was 13.7% in FY26 (consolidated figures).

### Is Laxmi Dental a debt-free company?

Laxmi Dental is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Laxmi Dental's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Laxmi Dental reported revenue of ₹72 Cr, +19.5% year on year, and net profit of ₹11 Cr, +201.4% year on year.

### How has Laxmi Dental stock performed over the last year?

Laxmi Dental's share price has fallen 42.7% over the past year, −19.2% over three months and −8.0% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Laxmi Dental?

As of 30 Jun 2026: promoters 41.80%, foreign institutions 30.10%, domestic institutions 10.89%, non-institutions 17.21%.

### Who are Laxmi Dental's competitors?

The listed Pharma & Healthcare companies closest to Laxmi Dental by market cap are Bajaj Healthcare, Bafna Pharmaceuticals, Lincoln Pharmaceuticals, Sigachi Industries, Themis Medicare and Shree Ganesh Re.

### Is Laxmi Dental a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Laxmi Dental's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on LAXMIDENTL against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.